...
search icon
mygn-img

Myriad Genetics Inc Share Price

MYGN
NSQ
$4.49
-$0.04
(-0.88%)
1D
Industry: Biotechnology Sector: Health Care

Myriad Genetics Inc Analyst Forecast

Myriad Genetics Inc Share Price Chart

Myriad Genetics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$418.53M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.04M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.89
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.76 L
$15.47 H
$4.49

About Myriad Genetics Inc, Common Stock

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests. The company offers molecular diagnostic tests for oncology, women's health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test to help determine the therapy for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; Memorial Sloan Kettering Cancer Center; the University of Texas MD Anderson Cancer Center; the University of Rochester Medical Center; and Flatiron Health, Inc. The company has a strategic alliance with SOPHiA GENETICS SA for the development of liquid biopsy companion diagnostic (CDx) test. The co more

Industry: BiotechnologySector: Health Care

Myriad Genetics Inc Stock Returns

Time FrameMYGNSectorS&P500
1-Week Return-12.3%-0.03%-1.38%
1-Month Return-27.58%0.59%-1.81%
3-Month Return-29.29%3.23%1.38%
6-Month Return-23.51%18.29%5.68%
1-Year Return-69.35%7.71%11.74%
3-Year Return-76.32%18.03%65.15%
5-Year Return-85.04%35.78%73.68%
10-Year Return-87.33%140.42%260.03%

Myriad Genetics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue557.00M690.60M678.40M753.20M837.60M[{"date":"2020-12-31","value":66.5,"profit":true},{"date":"2021-12-31","value":82.45,"profit":true},{"date":"2022-12-31","value":80.99,"profit":true},{"date":"2023-12-31","value":89.92,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue178.20M197.60M202.00M236.20M252.20M[{"date":"2020-12-31","value":70.66,"profit":true},{"date":"2021-12-31","value":78.35,"profit":true},{"date":"2022-12-31","value":80.1,"profit":true},{"date":"2023-12-31","value":93.66,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit378.80M493.00M476.40M517.00M585.40M[{"date":"2020-12-31","value":64.71,"profit":true},{"date":"2021-12-31","value":84.22,"profit":true},{"date":"2022-12-31","value":81.38,"profit":true},{"date":"2023-12-31","value":88.32,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin68.01%71.39%70.22%68.64%69.89%[{"date":"2020-12-31","value":95.27,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.37,"profit":true},{"date":"2023-12-31","value":96.15,"profit":true},{"date":"2024-12-31","value":97.9,"profit":true}]
Operating Expenses653.30M683.50M617.00M774.40M708.90M[{"date":"2020-12-31","value":84.36,"profit":true},{"date":"2021-12-31","value":88.26,"profit":true},{"date":"2022-12-31","value":79.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":91.54,"profit":true}]
Operating Income(194.80M)(190.50M)(140.60M)(257.40M)(123.50M)[{"date":"2020-12-31","value":-19480000000,"profit":false},{"date":"2021-12-31","value":-19050000000,"profit":false},{"date":"2022-12-31","value":-14060000000,"profit":false},{"date":"2023-12-31","value":-25740000000,"profit":false},{"date":"2024-12-31","value":-12350000000,"profit":false}]
Total Non-Operating Income/Expense-127.50M(17.50M)(5.20M)(35.50M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-13.73,"profit":false},{"date":"2023-12-31","value":-4.08,"profit":false},{"date":"2024-12-31","value":-27.84,"profit":false}]
Pre-Tax Income(283.70M)(57.10M)(140.60M)(262.20M)(123.50M)[{"date":"2020-12-31","value":-28370000000,"profit":false},{"date":"2021-12-31","value":-5710000000,"profit":false},{"date":"2022-12-31","value":-14060000000,"profit":false},{"date":"2023-12-31","value":-26220000000,"profit":false},{"date":"2024-12-31","value":-12350000000,"profit":false}]
Income Taxes59.90M(29.90M)(28.60M)1.10M3.80M[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-49.92,"profit":false},{"date":"2022-12-31","value":-47.75,"profit":false},{"date":"2023-12-31","value":1.84,"profit":true},{"date":"2024-12-31","value":6.34,"profit":true}]
Income After Taxes-(27.20M)(112.00M)(263.30M)(127.30M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2720000000,"profit":false},{"date":"2022-12-31","value":-11200000000,"profit":false},{"date":"2023-12-31","value":-26330000000,"profit":false},{"date":"2024-12-31","value":-12730000000,"profit":false}]
Income From Continuous Operations-(27.20M)(112.00M)(263.30M)(127.30M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-2720000000,"profit":false},{"date":"2022-12-31","value":-11200000000,"profit":false},{"date":"2023-12-31","value":-26330000000,"profit":false},{"date":"2024-12-31","value":-12730000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(223.70M)(27.20M)(112.00M)(263.30M)(127.30M)[{"date":"2020-12-31","value":-22370000000,"profit":false},{"date":"2021-12-31","value":-2720000000,"profit":false},{"date":"2022-12-31","value":-11200000000,"profit":false},{"date":"2023-12-31","value":-26330000000,"profit":false},{"date":"2024-12-31","value":-12730000000,"profit":false}]
EPS (Diluted)(0.66)0.02(0.30)(0.28)0.13[{"date":"2020-12-31","value":-507.69,"profit":false},{"date":"2021-12-31","value":15.38,"profit":true},{"date":"2022-12-31","value":-230.77,"profit":false},{"date":"2023-12-31","value":-215.38,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]

Myriad Genetics Inc Ratios

Myriad Genetics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

MYGN
Cash Ratio 0.98
Current Ratio 2.33
Quick Ratio 2.12

Myriad Genetics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MYGN
ROA (LTM) -5.67%
ROE (LTM) -72.52%

Myriad Genetics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MYGN
Debt Ratio Lower is generally better. Negative is bad. 0.49
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.51

Myriad Genetics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MYGN
Trailing PE NM
Forward PE 54.05
P/S (TTM) 0.51
P/B 1.12
Price/FCF 23
EV/R 0.59
EV/Ebitda NM
PEG 1.40

FAQs

What is Myriad Genetics Inc share price today?

Myriad Genetics Inc (MYGN) share price today is $4.49

Can Indians buy Myriad Genetics Inc shares?

Yes, Indians can buy shares of Myriad Genetics Inc (MYGN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MYGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Myriad Genetics Inc be purchased?

Yes, you can purchase fractional shares of Myriad Genetics Inc (MYGN) via the Vested app. You can start investing in Myriad Genetics Inc (MYGN) with a minimum investment of $1.

How to invest in Myriad Genetics Inc shares from India?

You can invest in shares of Myriad Genetics Inc (MYGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in MYGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Myriad Genetics Inc shares
What is Myriad Genetics Inc 52-week high and low stock price?

The 52-week high price of Myriad Genetics Inc (MYGN) is $15.47. The 52-week low price of Myriad Genetics Inc (MYGN) is $3.76.

What is Myriad Genetics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Myriad Genetics Inc (MYGN) is

What is Myriad Genetics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Myriad Genetics Inc (MYGN) is 1.12

What is Myriad Genetics Inc dividend yield?

The dividend yield of Myriad Genetics Inc (MYGN) is 0.00%

What is the Market Cap of Myriad Genetics Inc?

The market capitalization of Myriad Genetics Inc (MYGN) is $418.53M

What is Myriad Genetics Inc's stock symbol?

The stock symbol (or ticker) of Myriad Genetics Inc is MYGN

How Can Investors Use Myriad Genetics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Myriad Genetics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Myriad Genetics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Myriad Genetics Inc shares for Indian investors?

When investing in Myriad Genetics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Myriad Genetics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Myriad Genetics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Myriad Genetics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Myriad Genetics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top